These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 22110136)

  • 1. Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.
    Yu ED; Girardi E; Wang J; Mac TT; Yu KO; Van Calenbergh S; Porcelli SA; Zajonc DM
    J Biol Chem; 2012 Jan; 287(2):1269-78. PubMed ID: 22110136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode.
    Li Y; Girardi E; Wang J; Yu ED; Painter GF; Kronenberg M; Zajonc DM
    J Exp Med; 2010 Oct; 207(11):2383-93. PubMed ID: 20921281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
    López-Sagaseta J; Kung JE; Savage PB; Gumperz J; Adams EJ
    PLoS Biol; 2012; 10(10):e1001412. PubMed ID: 23109910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
    Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2355. PubMed ID: 31649670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
    Pellicci DG; Patel O; Kjer-Nielsen L; Pang SS; Sullivan LC; Kyparissoudis K; Brooks AG; Reid HH; Gras S; Lucet IS; Koh R; Smyth MJ; Mallevaey T; Matsuda JL; Gapin L; McCluskey J; Godfrey DI; Rossjohn J
    Immunity; 2009 Jul; 31(1):47-59. PubMed ID: 19592275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of bovine CD1d reveal altered αGalCer presentation and a restricted A' pocket unable to bind long-chain glycolipids.
    Wang J; Guillaume J; Pauwels N; Van Calenbergh S; Van Rhijn I; Zajonc DM
    PLoS One; 2012; 7(10):e47989. PubMed ID: 23110152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
    Jervis PJ; Polzella P; Wojno J; Jukes JP; Ghadbane H; Garcia Diaz YR; Besra GS; Cerundolo V; Cox LR
    Bioconjug Chem; 2013 Apr; 24(4):586-94. PubMed ID: 23458425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
    Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
    J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties.
    Uldrich AP; Patel O; Cameron G; Pellicci DG; Day EB; Sullivan LC; Kyparissoudis K; Kjer-Nielsen L; Vivian JP; Cao B; Brooks AG; Williams SJ; Illarionov P; Besra GS; Turner SJ; Porcelli SA; McCluskey J; Smyth MJ; Rossjohn J; Godfrey DI
    Nat Immunol; 2011 Jun; 12(7):616-23. PubMed ID: 21666690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.
    Pellicci DG; Clarke AJ; Patel O; Mallevaey T; Beddoe T; Le Nours J; Uldrich AP; McCluskey J; Besra GS; Porcelli SA; Gapin L; Godfrey DI; Rossjohn J
    Nat Immunol; 2011 Jul; 12(9):827-33. PubMed ID: 21804559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
    Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
    J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface.
    Brennan PJ; Cheng TY; Pellicci DG; Watts GFM; Veerapen N; Young DC; Rossjohn J; Besra GS; Godfrey DI; Brenner MB; Moody DB
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8348-8353. PubMed ID: 28716901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
    Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
    Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
    Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
    Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens.
    Girardi E; Maricic I; Wang J; Mac TT; Iyer P; Kumar V; Zajonc DM
    Nat Immunol; 2012 Sep; 13(9):851-6. PubMed ID: 22820602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
    Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
    J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.
    Halder RC; Tran C; Prasad P; Wang J; Nallapothula D; Ishikawa T; Wang M; Zajonc DM; Singh RR
    Eur J Immunol; 2019 Feb; 49(2):242-254. PubMed ID: 30508304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.
    Patel O; Pellicci DG; Uldrich AP; Sullivan LC; Bhati M; McKnight M; Richardson SK; Howell AR; Mallevaey T; Zhang J; Bedel R; Besra GS; Brooks AG; Kjer-Nielsen L; McCluskey J; Porcelli SA; Gapin L; Rossjohn J; Godfrey DI
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19007-12. PubMed ID: 22065767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.